Actively Recruiting
Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-03-04
300
Participants Needed
1
Research Sites
198 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to evaluate the cardiovascular health and prognosis of adult patients with cancer, treated with cardiotoxic therapies. The main purposes of the study are the following: * Identify the demographic factors related to the onset of cardiotoxicity produced by anticancer drugs. * Identify any subgroups more likely to develop distant major adverse cardiovascular events (MACE). * Evaluate the usefulness of clinical, biohumoral and echocardiographic parameters for early diagnosis of cardiotoxicity. Participants will be monitored during the anticancer treatment via clinical, laboratory and instrumental evaluation according to the recommendation of the current guidelines on Cardio-Oncology (European Society of Cardiology, 2022). Initial follow-up will be 2 years.
CONDITIONS
Official Title
Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over the age of 18 at the time of evaluation
- Patients treated with potentially cardiotoxic anticancer drugs
- Patients with complete clinical, electrocardiographic, and echocardiographic data available at first evaluation and at least one follow-up visit
You will not qualify if you...
- Patients under the age of 18 at the time of evaluation
- Patients whose documentation of the first visit is not available
- Patients for whom it is not possible to obtain follow-up information through a medical visit or by telephone
- Patients with poor acoustic window for echocardiographic examination
- Refusal of informed consent to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione Policlinico Universitario A. Gemelli IRCCS;UOSD diagnostica cardiologica non invasiva
Rome, Lazio, Italy, 00168
Actively Recruiting
Research Team
A
Antonella Lombardo
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here